Akhil Farma Limited

Akhil Farma Limited

Pharmaceutical company specializing in manufacturing, importing, and selling various medical products and equipment.
1990 | Mumbai, Maharashtra (India) | Active

Last Updated:

July 04, 2024
HomeCompanyAkhil Farma Limited

Who are the key members and board of directors at Akhil Farma?

Board Members(3)

NameDesignationAppointment DateStatus
Anil Nadkarni In Whole-Time Director 14-Jan-2000Current
Chandrayani Nayak In Whole-Time Director 01-Dec-2001Current
Meera Chandavarkar In Director 01-Apr-2015Current

Financial Performance and Corporate Structure Insights of Akhil Farma.

Akhil Farma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1009.62% increase. The company also saw a substantial improvement in profitability, with a 1477.7% increase in profit. The company's net worth Soared by an impressive increase of 36.96%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
1009.62%
Revenue from Operations
Total Assets
36.97%
Profit or Loss
1477.70%
Net Worth
36.96%
EBITDA
-148.92%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹0.80 M

LenderAmountStatus

Canara Bank

Creation Date: 26 Mar 1987
₹0.80 MOpen

How Many Employees Work at Akhil Farma?

Unlock and access historical data on people associated with Akhil Farma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Akhil Farma

Recent activity within the organization

  • Annual General Meeting

    Akhil Farma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Akhil Farma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Meera Ramdas Chandavarkar was appointed as a Director was appointed as a Director on 01 Apr 2015 & has been associated with this company since 9 years 8 months .

    01 Apr 2015

  • Director Appointment

    Chandrayani Venugopal Nayak was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Dec 2001 & has been associated with this company since 23 years 20 days .

    01 Dec 2001

  • Director Appointment

    Anil Nadkarni was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 14 Jan 2000 & has been associated with this company since 24 years 11 months .

    14 Jan 2000

  • Charges

    A charge with Canara Bank of Rs. 0.80 M registered on 26 Mar 1987 with Charge ID 90164789 was modified on 28 Dec 1990.

    28 Dec 1990

Frequently asked questions

  • Akhil Farma Limited was incorporated on 09 Mar 1990.

  • The authorized share capital of Akhil Farma Limited is ₹ 5.00 M and paid-up capital is ₹ 4.19 M.

  • Currently 3 directors are associated with Akhil Farma Limited.

    • Anil Nadkarni
    • Chandrayani Venugopal Nayak
    • Meera Ramdas Chandavarkar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Akhil Farma Limited is 142 Chaswala Estates V Road, Jogeshwari West, Mumbai, Maharashtra, India, 400102.

  • The corporate identification number (CIN) of Akhil Farma Limited is U51397MH1990PLC055739 and the company number is 055739 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Akhil Farma Limited has risen by 1009.62%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Akhil Farma Limited has experienced an upsurge of 36.96%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Akhil Farma Limited amount to ₹ 0.80 M.

  • The most recent Balance Sheet for Akhil Farma Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development